Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Theravance Biopharma Share Holder Equity 2012-2025 | TBPH

Theravance Biopharma share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Theravance Biopharma Annual Share Holder Equity
(Millions of US $)
2024 $176
2023 $213
2022 $442
2021 $-339
2020 $-304
2019 $-224
2018 $-52
2017 $115
2016 $350
2015 $243
2014 $290
2013 $-17
2012 $-7
2011 $0
Theravance Biopharma Quarterly Share Holder Equity
(Millions of US $)
2025-09-30 $233
2025-06-30 $225
2025-03-31 $166
2024-12-31 $176
2024-09-30 $186
2024-06-30 $194
2024-03-31 $205
2023-12-31 $213
2023-09-30 $246
2023-06-30 $280
2023-03-31 $371
2022-12-31 $442
2022-09-30 $481
2022-06-30 $-350
2022-03-31 $-351
2021-12-31 $-339
2021-09-30 $-324
2021-06-30 $-300
2021-03-31 $-373
2020-12-31 $-304
2020-09-30 $-262
2020-06-30 $-202
2020-03-31 $-158
2019-12-31 $-224
2019-09-30 $-183
2019-06-30 $-137
2019-03-31 $-113
2018-12-31 $-52
2018-09-30 $-13
2018-06-30 $34
2018-03-31 $63
2017-12-31 $115
2017-09-30 $184
2017-06-30 $241
2017-03-31 $294
2016-12-31 $350
2016-09-30 $298
2016-06-30 $322
2016-03-31 $239
2015-12-31 $243
2015-09-30 $223
2015-06-30 $258
2015-03-31 $289
2014-12-31 $290
2014-09-30 $340
2014-06-30 $385
2014-03-31 $-18
2013-12-31 $-17
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $-7
2011-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.914B $0.064B
Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.154B 33.86
Zoetis (ZTS) United States $52.354B 18.74
Takeda Pharmaceutical (TAK) Japan $44.993B 9.18
BeOne Medicines - (ONC) Switzerland $44.644B 218.97
Daiichi Sankyo, - (DSNKY) Japan $41.960B 20.90
Sandoz Group AG (SDZNY) Switzerland $30.210B 0.00
United Therapeutics (UTHR) United States $20.319B 17.88
Merck (MKKGY) Germany $17.344B 10.69
Shionogi (SGIOY) Japan $14.581B 13.39
Neurocrine Biosciences (NBIX) United States $14.314B 34.34
Summit Therapeutics (SMMT) United States $13.071B 0.00
IPSEN (IPSEY) France $12.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.569B 0.00
Ionis Pharmaceuticals (IONS) United States $11.866B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.668B 0.00
Corcept Therapeutics (CORT) United States $7.902B 85.36
Stevanato Group S.p.A (STVN) Italy $6.514B 36.46
Grifols, S.A (GRFS) Spain $5.844B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.372B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.672B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.640B 17.28
Hypermarcas (HYPMY) Brazil $3.072B 21.09
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Dyne Therapeutics (DYN) United States $2.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.773B 8.85
Soleno Therapeutics (SLNO) United States $2.538B 0.00
Ocular Therapeutix (OCUL) United States $2.533B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.248B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.042B 24.20
Guardian Pharmacy Services (GRDN) United States $1.794B 34.55
Amylyx Pharmaceuticals (AMLX) United States $1.535B 0.00
Harrow (HROW) United States $1.492B 91.57
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.436B 0.00
Collegium Pharmaceutical (COLL) United States $1.433B 7.10
Oruka Therapeutics (ORKA) United States $1.367B 0.00
Enliven Therapeutics (ELVN) United States $1.291B 0.00
Nektar Therapeutics (NKTR) United States $1.212B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Relay Therapeutics (RLAY) United States $1.147B 0.00
Xencor (XNCR) United States $1.115B 0.00
Evotec AG (EVO) Germany $1.052B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Savara (SVRA) United States $0.855B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.772B 6.89
Organogenesis (ORGO) United States $0.760B 0.00
KalVista Pharmaceuticals (KALV) United States $0.751B 0.00
ARS Pharmaceuticals (SPRY) United States $0.724B 0.00
Aquestive Therapeutics (AQST) United States $0.710B 0.00
Lexeo Therapeutics (LXEO) United States $0.692B 0.00
Esperion Therapeutics (ESPR) United States $0.674B 0.00
ProKidney (PROK) United States $0.662B 0.00
4D Molecular Therapeutics (FDMT) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.624B 0.00
Bioventus (BVS) United States $0.584B 11.97
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.508B 12.04
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Altimmune (ALT) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.423B 5.78
Galectin Therapeutics (GALT) United States $0.387B 0.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 21.39
USANA Health Sciences (USNA) United States $0.346B 9.65
Silence Therapeutics (SLN) United Kingdom $0.316B 0.00
Avalo Therapeutics (AVTX) United States $0.306B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Larimar Therapeutics (LRMR) United States $0.292B 0.00
Pyxis Oncology (PYXS) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.265B 0.00
Achieve Life Sciences (ACHV) Canada $0.234B 0.00
OmniAb (OABI) United States $0.219B 0.00
Protara Therapeutics (TARA) United States $0.215B 0.00
AleAnna (ANNA) United States $0.211B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Relmada Therapeutics (RLMD) United States $0.132B 0.00
Unicycive Therapeutics (UNCY) United States $0.124B 0.00
Avita Medical (RCEL) United States $0.118B 0.00
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Prelude Therapeutics (PRLD) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.099B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
VAXART, INC (VXRT) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.093B 33.75
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Acrivon Therapeutics (ACRV) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Fractyl Health (GUTS) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.070B 0.00
Plus Therapeutics (PSTV) United States $0.065B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Talphera (TLPH) United States $0.062B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Wellgistics Health (WGRX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
Liminatus Pharma (LIMN) United States $0.029B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.028B 23.75
Vyome Holdings (HIND) United States $0.028B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Inotiv (NOTV) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00